Fabrication of human skin equivalents using droplet-based bioprinting

A novel approach for the formulation of human skin equivalents (hSKE) has been developed, combining droplet-based 3D bioprinting and nebulization technology.1

This technique differs from traditional manual or extrusion-based methods as it facilitates high reproducibility, uniformity, and enhanced cell viability in skin constructs.

Methodology

  • Dermis was created by printing collagen bioink with human dermal fibroblasts. These were stabilized by using nebulized sodium bicarbonate as a crosslinking agent.
  • Epidermis formation was achieved by printing keratinocyte bioink, followed by the development of an air-liquid interface culture to induce stratification.
  • Constructs were compared with native mouse and human skin in order to confirm morphological similarity.
  • A skin grafting model was used to evaluate efficacy.

Outcome

1.Bioprinted hSKE mimics native skin

hSKE fabricated via droplet-based bioprinting and nebulization techniques has the potential to effectively replicate native skin’s dermal and epidermal architecture, including keratinocytes’ keratinization process within the epidermis.

2. Cell viability

Droplet-based printing at low pressure has been shown to preserve fibroblasts and keratinocytes, offering survival rates of >84 %.

3. Therapeutic efficacy

The use of hSKE transplantation in wound healing models has been shown to:

  • Accelerate wound closure
  • Promote vascularization, offering two times more blood vessels versus collagen-only controls
  • Support organized dermal regeneration and mature collagen deposition

4. Advantages of nebulization

Nebulization was found to prevent nozzle clogging by spraying crosslinking agents as a fine mist. This also enabled the printing of low-viscosity collagen bioinks with no cell loss.

Diagram illustrating the fabrication of hSKE using droplet-based bioprinting with nebulization. A: Droplet nozzle, B: Nebulizer spray, C: Printing design, D: Printed collagen, E: Fibroblasts in collagen (at days zero and one), F: Schematic of hSKE fabrication. Scale bar: 200 μm.

Figure 1. Fabrication of hSKE using droplet-based bioprinting with nebulization. A: Droplet nozzle, B: Nebulizer spray, C: Printing design, D: Printed collagen, E: Fibroblasts in collagen (day zero and day one), F: Schematic of hSKE fabrication. Scale bar: 200 μm. Image Credit: Molecular & Cellular Toxicology (2023)

Comparison of morphological similarities between manufactured hSKE and native skin through H&E staining. A Human native skin isolated from circum tissue. B Mouse native skin sampled from the skin of nude mice. C hSKE produced by printing each major cell.

Figure 2. Comparison of morphological similarities between manufactured hSKE and native skin through H&E staining. A: Human native skin isolated from circum tissue. B: Mouse native skin sampled from the skin of nude mice. C: hSKE produced by printing each major cell. Scale bar: 100 μm. Image Credit: Molecular & Cellular Toxicology (2023)

Conclusion

Nebulization-enabled droplet bioprinting is a powerful fabrication method, enabling the production of scalable, reproducible, and functional human skin equivalents.

This approach also offers significant promise as a New Approach Methodology (NAM) in cosmetics, dermatology, and drug development.

Future work in this area is expected to focus on hiPSC-derived skin equivalents, facilitating the delivery of patient-specific and personalized skin therapies.

References and further reading

  1. Lee, S.-G., et al. (2023). Evaluation of the therapeutic efficacy of human skin equivalents manufactured through droplet-based bioprinting/nebulization technology. Molecular & Cellular Toxicology. (online) DOI: 10.1007/s13273-023-00330-9. https://link.springer.com/article/10.1007/s13273-023-00330-9.

About Scintica Instrumentation Inc.

At Scintica, we advance science and medicine by supplying researchers with reliable research instrumentation and equipment. Our carefully selected portfolio of imaging systems, research tools, and supporting technologies is designed to reduce complexity and help scientists focus on what matters most, generating
meaningful results.
 
We partner closely with the preclinical research community to connect teams with solutions that are scientifically robust and built to support research challenges. From system selection through long-term support, our goal is to make research more productive, efficient, and impactful.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: May 14, 2026 at 11:29 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scintica Instrumentation Inc.. (2026, May 14). Fabrication of human skin equivalents using droplet-based bioprinting. News-Medical. Retrieved on May 14, 2026 from https://www.news-medical.net/whitepaper/20260514/Fabrication-of-human-skin-equivalents-using-droplet-based-bioprinting.aspx.

  • MLA

    Scintica Instrumentation Inc.. "Fabrication of human skin equivalents using droplet-based bioprinting". News-Medical. 14 May 2026. <https://www.news-medical.net/whitepaper/20260514/Fabrication-of-human-skin-equivalents-using-droplet-based-bioprinting.aspx>.

  • Chicago

    Scintica Instrumentation Inc.. "Fabrication of human skin equivalents using droplet-based bioprinting". News-Medical. https://www.news-medical.net/whitepaper/20260514/Fabrication-of-human-skin-equivalents-using-droplet-based-bioprinting.aspx. (accessed May 14, 2026).

  • Harvard

    Scintica Instrumentation Inc.. 2026. Fabrication of human skin equivalents using droplet-based bioprinting. News-Medical, viewed 14 May 2026, https://www.news-medical.net/whitepaper/20260514/Fabrication-of-human-skin-equivalents-using-droplet-based-bioprinting.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.